dorzolamide
Selected indexed studies
- Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future. (Adv Ther, 2021) [PMID:33108623]
- Clinical pharmacokinetics of dorzolamide. (Clin Pharmacokinet, 2002) [PMID:11929320]
- Topical dorzolamide 2%/timolol 0.5%: a review of its use in the treatment of open-angle glaucoma. (Drugs Aging, 2000) [PMID:11200308]
_Worker-drafted node — pending editorial review._
Connections
dorzolamide is a side effect of
Sources
- Hypokalemia associated with topical administration of dorzolamide 2% ophthalmic solution in cats. (2021) pubmed
- Clinical pharmacokinetics of dorzolamide. (2002) pubmed
- Latanoprost versus combined timolol and dorzolamide. (2002) pubmed
- Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future. (2021) pubmed
- Topical dorzolamide 2%/timolol 0.5%: a review of its use in the treatment of open-angle glaucoma. (2000) pubmed
- Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension. (1997) pubmed
- Dorzolamide: development and clinical application of a topical carbonic anhydrase inhibitor. (1997) pubmed
- Dorzolamide, a 40-year wait. From an oral to a topical carbonic anhydrase inhibitor for the treatment of glaucoma. (1998) pubmed
- Topical dorzolamide for macular holes: A randomised, double-blind, placebo-controlled trial. (2024) pubmed
- Topical drug delivery to the eye: dorzolamide. (2012) pubmed